Neovasc Cost of Revenue 2011-2026 | NVCN

Cost of Revenue is a financial metric that reflects all direct costs associated with the production of goods or the provision of services that directly led to revenue during the reporting period. It is the total amount of expenses incurred by the company to deliver its products or services, including both production costs and related expenses necessary for delivery or customer support.

What is included in the cost of revenue

Cost Category	Examples
Production Costs	Materials, wages of production staff, depreciation of equipment
Service and Support	Customer service, user support, technical assistance
Delivery and Logistics	Packaging, delivery of goods to customers
Hosting and Infrastructure	Servers, cloud platforms (especially for IT and SaaS companies)
Content and Licenses	License purchases, production royalties (e.g., in streaming services)

Importance of the Metric

Helps to understand how costly the revenue-generating process is.
A high cost of revenue may indicate:
Poor cost control
Low operational efficiency
A low cost of revenue combined with high revenue indicates high profitability and business competitiveness.

Annual Cost of Revenue Neovasc

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
556 K	446 K	458 K	366 K	3.48 M	7.09 M	6.94 M	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
7.09 M	366 K	2.76 M

Cost of Revenue of other stocks in the Medical devices industry

Issuer	Cost of Revenue	Price	% 24h	Market Cap	Country
Align Technology ALGN	1.2 B	$ 184.69	2.23 %	$ 13.8 B	USA
Avinger AVGR	5.65 M	-	-20.74 %	$ 369 K	USA
Axonics Modulation Technologies AXNX	76 M	-	-	$ 3.31 B	USA
Aziyo Biologics AZYO	5.7 M	-	1.37 %	$ 20.5 M	USA
AxoGen AXGN	57.9 M	$ 34.46	2.96 %	$ 1.59 B	USA
BioSig Technologies BSGM	57 K	-	37.08 %	$ 85.7 M	USA
Conformis CFMS	38.8 M	-	-	$ 16.4 M	USA
Acutus Medical AFIB	10.3 M	-	-26.83 %	$ 2.62 M	USA
AdaptHealth Corp. AHCO	2.64 B	$ 12.77	3.65 %	$ 1.73 B	USA
Allied Healthcare Products AHPI	24.5 M	-	3.58 %	$ 2.21 M	USA
Bio-Rad Laboratories BIO	1.19 B	$ 292.23	1.41 %	$ 8.24 B	USA
Cytosorbents Corporation CTSO	10.6 M	$ 0.59	0.67 %	$ 36.7 M	USA
EDAP TMS S.A. EDAP	37.6 M	$ 3.37	1.35 %	$ 126 M	France
Bruker Corporation BRKR	1.72 B	$ 39.9	2.18 %	$ 5.94 K	USA
Boston Scientific Corporation BSX	6.22 B	$ 63.82	1.01 %	$ 94.5 B	USA
Apollo Endosurgery APEN	34.4 M	-	-	$ 475 M	USA
Cardiovascular Systems CSII	63.4 M	-	0.15 %	$ 844 M	USA
Inogen INGN	194 M	$ 6.34	-1.71 %	$ 169 M	USA
IRIDEX Corporation IRIX	33.4 M	$ 1.03	-	$ 17.4 M	USA
ClearPoint Neuro CLPT	14.3 M	$ 10.38	3.7 %	$ 294 M	USA
Dynatronics Corporation DYNT	21.4 M	-	14.99 %	$ 929 K	USA
Second Sight Medical Products EYES	11.4 M	-	-0.97 %	$ 54.4 M	USA
Electromed ELMD	14 M	$ 25.21	1.47 %	$ 213 M	USA
LENSAR LNSR	31.3 M	$ 6.04	2.03 %	$ 72.2 M	USA
GBS GBS	1.81 M	-	-0.57 %	$ 7.12 M	USA
Globus Medical GMED	958 M	$ 94.94	2.11 %	$ 12.8 B	USA
Helius Medical Technologies HSDT	583 K	$ 1.98	-2.46 %	$ 1.2 M	USA
Butterfly Network BFLY	33.2 M	$ 4.44	3.74 %	$ 940 M	USA
Myomo MYO	14 M	$ 0.79	8.49 %	$ 33.1 M	USA
BIOLASE BIOL	32.4 M	-	-13.19 %	$ 166 K	USA
OrthoPediatrics Corp. KIDS	63.7 M	$ 17.86	5.37 %	$ 419 M	USA
Delcath Systems DCTH	11.8 M	$ 10.88	4.11 %	$ 390 M	USA
Inspire Medical Systems INSP	133 M	$ 56.83	3.48 %	$ 1.67 B	USA
CONMED Corporation CNMD	624 M	$ 39.73	3.3 %	$ 1.23 B	USA
LivaNova PLC LIVN	448 M	$ 64.99	0.63 %	$ 3.55 B	Britain
Integer Holdings Corporation ITGR	1.35 B	$ 88.63	1.03 %	$ 3.08 B	USA
Invacare Corporation IVC	566 M	-	-	$ 24.7 M	USA
Edwards Lifesciences Corporation EW	1.33 B	$ 78.2	0.1 %	$ 45.7 B	USA